Cytokinetics, Inc. (CYTK)
56.16
-2.37
(-4.05%)
USD |
NASDAQ |
Nov 12, 16:00
56.16
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Price : 56.16 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 58.30 | 58.58 | 55.67 | 56.16 | 2.009M |
| Nov 11, 2026 | 56.40 | 59.08 | 55.74 | 58.53 | 2.812M |
| Nov 10, 2026 | 54.67 | 57.21 | 54.12 | 56.18 | 2.358M |
| Nov 09, 2026 | 54.38 | 55.85 | 53.58 | 55.14 | 3.120M |
| Nov 06, 2026 | 55.70 | 56.50 | 53.55 | 53.69 | 2.563M |
| Nov 05, 2026 | 60.04 | 60.84 | 54.16 | 55.55 | 6.776M |
| Nov 04, 2026 | 64.06 | 64.96 | 60.98 | 63.60 | 2.917M |
| Nov 03, 2026 | 62.74 | 64.37 | 62.05 | 62.31 | 1.699M |
| Nov 02, 2026 | 63.40 | 64.00 | 61.96 | 62.03 | 1.561M |
| Oct 30, 2026 | 63.44 | 64.50 | 62.55 | 62.99 | 1.257M |
| Oct 29, 2026 | 62.08 | 63.95 | 61.54 | 63.31 | 1.425M |
| Oct 28, 2026 | 60.86 | 61.39 | 60.14 | 61.28 | 1.274M |
| Oct 27, 2026 | 60.68 | 61.83 | 60.47 | 61.52 | 1.148M |
| Oct 26, 2026 | 61.45 | 61.89 | 60.48 | 60.73 | 783239.0 |
| Oct 23, 2026 | 62.01 | 62.44 | 60.89 | 61.23 | 985633.0 |
| Oct 22, 2026 | 63.01 | 64.07 | 61.94 | 62.33 | 2.061M |
| Oct 21, 2026 | 64.30 | 64.78 | 62.46 | 62.86 | 1.081M |
| Oct 20, 2026 | 63.13 | 64.76 | 62.88 | 63.95 | 1.050M |
| Oct 19, 2026 | 62.06 | 63.60 | 61.84 | 62.65 | 1.913M |
| Oct 16, 2026 | 63.90 | 63.90 | 61.68 | 61.95 | 1.205M |
| Oct 15, 2026 | 64.81 | 65.57 | 63.81 | 63.92 | 1.665M |
| Oct 14, 2026 | 61.62 | 64.01 | 60.99 | 63.43 | 2.096M |
| Oct 13, 2026 | 62.32 | 63.05 | 61.50 | 61.62 | 1.936M |
| Oct 12, 2026 | 62.48 | 63.50 | 62.13 | 62.79 | 1.254M |
| Oct 09, 2026 | 61.87 | 63.03 | 61.59 | 62.91 | 1.118M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BridgeBio Pharma, Inc. | 78.17 |
| Alnylam Pharmaceuticals, Inc. | 156.65 |
| BioMarin Pharmaceutical, Inc. | 56.70 |
| Exelixis, Inc. | 69.84 |
| Ionis Pharmaceuticals, Inc. | 27.31 |
Price Related Metrics
| PS Ratio | 64.05 |
| Earnings Yield | -10.75% |
| Market Cap | 7.819B |